{Topic Name}

Pharmaceutical Associates, a drugmaker based in Greenville, S.C., raised the price of its generic version of Prozac by 568 percent, according to The Financial Times.

Below are 13 legal actions involving the drug supply chain, including pharmaceutical companies, PBMs and distributors, reported by Becker's Hospital Review in the last month.

Several drugs are slated to make their debuts in 2019, but only seven are projected to achieve blockbuster status within four years, according to a new report from analytic firm Cortellis.

A California biotech claims that the controversial billionaire biotech entrepreneur Patrick Soon-Shiong, MD, orchestrated a "catch and kill" scheme to stop development of an experimental cancer drug that may have saved the U.S. healthcare system more than $1 billion, according…

Three drugmakers — Eli Lilly, Novo Nordisk and Sanofi — will testify at the House Energy and Commerce committee hearing on insulin prices April 10, according to The Hill.

Cigna and Express Scripts launched a program that limits members' out-of-pocket insulin costs to $25 for a 30-day supply, the companies said April 3.

Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group's pharmacy benefit manager OptumRx, is ending its drug compounding services at two Houston sites, according to the Houston Chronicle.

After missing analysts' second-quarter sales and earning expectations, Walgreens Boots Alliance vowed to cut more than $1.5 billion in costs by fiscal year 2022, according to CNBC.

A federal  judge in New York has ruled that Novartis must face trial in a case accusing the drugmaker of paying millions of dollars in kickbacks to physicians to boost prescription rates, according to Reuters.

An Oklahoma pharmacy owner has been charged with orchestrating a scheme that defrauded Medicare and Medicaid out of more than $1 million.